Type 2 diabetes. Type 2 diabetes mellitus
Conditions
Interventions
Considering the crossover nature of this clinical trial in the first intervention group (A): At first, during 3 days of first hospitalization week, the insulin injection is done by the researcher with
Sponsors
Rasht University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Patient must be between 18 to 75 years old patient must have type 2 diabetes patient must have used injecting insulin at least for 2 years patient BMI must be over 18/5 Patient should not be mentally retired or have any psychological disease patient must use insulin pen
Exclusion criteria
Exclusion criteria: Patient does not want to participate in the study. Patient has skin problems in the injection site. patient does not have diabetes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Comparison of 2 Pen Needles efficiency on patient Glycemic Control. Timepoint: Comparison of 2 Pen Needle gauges efficiency on patient Glycemic Control that patient blood sugar will be distinct in first ,third and 6th day. Method of measurement: patient blood sugar will be distinct by blood sampling and laboratory instruments.;Comparison of 2 pen needle Gauges efficiency on needle leakage. Timepoint: Comparison of 2 Pen Needle gauges efficiency on needle leakage that will be evaliated in first ,third and 6th day. Method of measurement: leakage will be approved by the researcher.;Comparison of 2 Pen Needles efficiency on patient pain while injection. Timepoint: Comparison of 2 Pen Needle gauges efficiency on needle pain that will be evaliated in first ,third and 6th day. Method of measurement: pain will be evaluated by the Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| None. Timepoint: None. Method of measurement: None. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactHossein Rafiei
Rasht University of Medical Sciences
Outcome results
None listed